CONTICELLO, CONCETTA MARIA SEBASTIANA
 Distribuzione geografica
Continente #
NA - Nord America 302
EU - Europa 137
AS - Asia 130
AF - Africa 50
SA - Sud America 18
Totale 637
Nazione #
US - Stati Uniti d'America 298
IT - Italia 85
SG - Singapore 52
CN - Cina 49
CI - Costa d'Avorio 40
BR - Brasile 15
IE - Irlanda 13
DE - Germania 12
KR - Corea 12
IN - India 7
SN - Senegal 7
FI - Finlandia 6
UA - Ucraina 6
CA - Canada 4
VN - Vietnam 4
GB - Regno Unito 3
JP - Giappone 3
RU - Federazione Russa 3
AR - Argentina 2
CZ - Repubblica Ceca 2
NL - Olanda 2
CH - Svizzera 1
CO - Colombia 1
EG - Egitto 1
FR - Francia 1
GR - Grecia 1
LU - Lussemburgo 1
MA - Marocco 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 637
Città #
Dallas 69
Santa Clara 52
Singapore 44
Chandler 41
Abidjan 40
Chicago 28
Hefei 21
Ashburn 18
Catania 18
Civitanova Marche 13
Dublin 13
Florence 13
Seoul 12
Boardman 8
Dakar 7
Los Angeles 7
Munich 7
Jacksonville 6
Helsinki 5
Andover 4
Beijing 4
Cambridge 4
Lawrence 4
Des Moines 3
Milan 3
New York 3
Washington 3
Bengaluru 2
Bremen 2
Brooklyn 2
Dalian 2
Dong Ket 2
Giarre 2
Grafing 2
Hanoi 2
Nanjing 2
Noida 2
Rome 2
Saint Petersburg 2
Tianjin 2
Tokyo 2
Toronto 2
Vicenza 2
Agrate Brianza 1
Amsterdam 1
Brno 1
Bronte 1
Buenaventura 1
Buffalo 1
Cairo 1
Caltagirone 1
Chennai 1
Chongqing 1
Columbus 1
Curitiba 1
Den Haag 1
Duncan 1
Flint 1
Fortaleza 1
Fukuoka 1
Genoa 1
Guangzhou 1
Honolulu 1
Houston 1
Indore 1
Itaberaba 1
Itabira 1
João Monlevade 1
Laayoune 1
Lahore 1
Langfang 1
Lu'an 1
Manchester 1
Mandaluyong 1
Melrose 1
Messina 1
Misterbianco 1
Nanchang 1
Ottawa 1
Pacajus 1
Paris 1
Pinhais 1
Pirenópolis 1
Redwood City 1
Rio de Janeiro 1
Salvador 1
San Luis 1
San Mateo 1
San Severo 1
Santa Vitória do Palmar 1
Seattle 1
Sorocaba 1
São Paulo 1
Tamm 1
Tashkent 1
The Dalles 1
Timbó 1
Torre A Mare 1
Três Lagoas 1
Turku 1
Totale 539
Nome #
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 147
NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS 108
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 98
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 93
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents 75
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 66
Multicentric Castleman disease and concurrent hematological disorders: the occurrence of plasmacytoma and the hypotheses arising from literature's review 62
Totale 649
Categoria #
all - tutte 2.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 7 6 1 6 3 5 1 1 5
2021/202244 2 6 0 0 9 1 4 2 3 7 0 10
2022/2023102 7 8 5 8 9 11 1 15 14 2 12 10
2023/202481 2 16 5 5 2 23 4 3 0 2 12 7
2024/2025216 5 46 11 21 38 34 6 10 11 11 15 8
2025/2026155 22 58 71 4 0 0 0 0 0 0 0 0
Totale 649